Additionally, ATRX mutations, EGFR (epidermal growth factor receptor) alterations, CD70, CD147, CDKN2A deletions, exosomes, cfDNA (cell-free DNA), ctDNA (circulating tumor DNA), and CTCs (circulating tumor cells) stand out as significant markers. The gene discussed is CDKN2A; the disease is neoplasm.